ENTRY       K03160                      KO
NAME        TNFRSF5, CD40
DEFINITION  tumor necrosis factor receptor superfamily member 5
PATHWAY     ko04060  Cytokine-cytokine receptor interaction
            ko04064  NF-kappa B signaling pathway
            ko04514  Cell adhesion molecules (CAMs)
            ko04620  Toll-like receptor signaling pathway
            ko04672  Intestinal immune network for IgA production
            ko05144  Malaria
            ko05145  Toxoplasmosis
            ko05166  HTLV-I infection
            ko05169  Epstein-Barr virus infection
            ko05202  Transcriptional misregulation in cancer
            ko05310  Asthma
            ko05320  Autoimmune thyroid disease
            ko05322  Systemic lupus erythematosus
            ko05330  Allograft rejection
            ko05340  Primary immunodeficiency
            ko05416  Viral myocarditis
DISEASE     H00086  Hyper IgM syndromes, autosomal recessive type
            H00093  Combined immunodeficiencies (CIDs)
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Environmental Information Processing
              Signal transduction
               04064 NF-kappa B signaling pathway
                K03160  TNFRSF5, CD40; tumor necrosis factor receptor superfamily member 5
              Signaling molecules and interaction
               04060 Cytokine-cytokine receptor interaction
                K03160  TNFRSF5, CD40; tumor necrosis factor receptor superfamily member 5
               04514 Cell adhesion molecules (CAMs)
                K03160  TNFRSF5, CD40; tumor necrosis factor receptor superfamily member 5
             Organismal Systems
              Immune system
               04620 Toll-like receptor signaling pathway
                K03160  TNFRSF5, CD40; tumor necrosis factor receptor superfamily member 5
               04672 Intestinal immune network for IgA production
                K03160  TNFRSF5, CD40; tumor necrosis factor receptor superfamily member 5
             Human Diseases
              Cancers
               05202 Transcriptional misregulation in cancers
                K03160  TNFRSF5, CD40; tumor necrosis factor receptor superfamily member 5
              Immune diseases
               05310 Asthma
                K03160  TNFRSF5, CD40; tumor necrosis factor receptor superfamily member 5
               05322 Systemic lupus erythematosus
                K03160  TNFRSF5, CD40; tumor necrosis factor receptor superfamily member 5
               05320 Autoimmune thyroid disease
                K03160  TNFRSF5, CD40; tumor necrosis factor receptor superfamily member 5
               05330 Allograft rejection
                K03160  TNFRSF5, CD40; tumor necrosis factor receptor superfamily member 5
               05340 Primary immunodeficiency
                K03160  TNFRSF5, CD40; tumor necrosis factor receptor superfamily member 5
              Cardiovascular diseases
               05416 Viral myocarditis
                K03160  TNFRSF5, CD40; tumor necrosis factor receptor superfamily member 5
              Infectious diseases
               05166 HTLV-I infection
                K03160  TNFRSF5, CD40; tumor necrosis factor receptor superfamily member 5
               05169 Epstein-Barr virus infection
                K03160  TNFRSF5, CD40; tumor necrosis factor receptor superfamily member 5
               05144 Malaria
                K03160  TNFRSF5, CD40; tumor necrosis factor receptor superfamily member 5
               05145 Toxoplasmosis
                K03160  TNFRSF5, CD40; tumor necrosis factor receptor superfamily member 5
            Cytokine receptors [BR:ko04050]
             TNF receptor family
              K03160  TNFRSF5, CD40; tumor necrosis factor receptor superfamily member 5
            Cell adhesion molecules and their ligands [BR:ko04516]
             7. Others
              TNFSF5, CD40L; tumor necrosis factor (ligand) superfamily, member 5
               K03160 TNFRSF5, CD40; tumor necrosis factor receptor superfamily member 5
            Cellular antigens [BR:ko04090]
             Proteins
              K03160  CD40; tumor necrosis factor receptor superfamily, member 5
GENES       HSA: 958(CD40)
            PTR: 100615583(CD40)
            PPS: 100974274(CD40)
            GGO: 101126651(CD40)
            PON: 100460237(CD40)
            MCC: 707749(CD40)
            MCF: 102118696(CD40)
            MMU: 21939(Cd40)
            RNO: 171369(Cd40)
            CGE: 100770242(Cd40)
            HGL: 101715501(Cd40)
            TUP: 102489413(CD40)
            CFA: 403469(CD40)
            AML: 100476345
            FCA: 101085363(CD40)
            PTG: 102972342(CD40)
            BTA: 286849(CD40)
            BOM: 102274192(CD40)
            PHD: 102320549(CD40)
            CHX: 102183249(CD40)
            SSC: 397395(CD40)
            CFR: 102510463(CD40)
            BACU: 103015045(CD40)
            LVE: 103071515(CD40)
            ECB: 100034049(CD40)
            MYB: 102261551(CD40)
            MYD: 102764122(CD40)
            PALE: 102890443(CD40)
            MDO: 100022240(CD40)
            SHR: 100935349(CD40)
            GGA: 395385(CD40)
            TGU: 100220945(CD40)
            FAB: 101814566(CD40)
            PHI: 102112115(CD40)
            APLA: 101793419(CD40)
            FPG: 101913161(CD40)
            FCH: 102059987(CD40)
            CLV: 102087204(CD40)
            ASN: 102368316(CD40)
            AMJ: 102563086(CD40)
            CMY: 102941434(CD40)
            PBI: 103064466(CD40)
            XTR: 100270675(cd40)
            DRE: 100270764(cd40)
            TRU: 100271746(cd40)
            MZE: 101478307 101487191
            OLA: 100301586
            XMA: 102228192
            LCM: 102356863(CD40)
            CMK: 103189936 103191363 103191371 103191377
REFERENCE   PMID:19426221
  AUTHORS   Elgueta R, Benson MJ, de Vries VC, Wasiuk A, Guo Y, Noelle RJ
  TITLE     Molecular mechanism and function of CD40/CD40L engagement in the immune system.
  JOURNAL   Immunol Rev 229:152-72 (2009)
///
